📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study. (2023)

First Author: Cerqueira-Silva T

Attributed to: Inequalities in health funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1004156

PubMed Identifier: 36630477

Publication URI: http://europepmc.org/abstract/MED/36630477

Type: Journal Article/Review

Volume: 20

Parent Publication: PLoS medicine

Issue: 1

ISSN: 1549-1277